Company intelligence / Profile preview

GenomiCare Biotechnology

Shanghai, Shanghai, China

Ownership: Private
Development stage: Commercial

Overview

GenomiCare Biotechnology offers a unique real-world data solution leveraging long-term engagement with cancer patients in China. Their platform accelerates global pharma/biotech companies’ ability to understand the Chinese oncology market, optimize regulatory approval processes, and improve access to innovative cancer therapies. No direct clinical results as they are not themselves a drug developer.

Therapeutic areas: Oncology
Modalities: Real-world data solutions
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Collaborates with global pharmaceutical companies seeking real-world evidence/data solutions in China’s oncology sector. Specific partner names are not disclosed.

Beyond the preview

Go deeper on GenomiCare Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GenomiCare Biotechnology.

Explore the full profile